TickerFacts.

Vanda Pharmaceuticals Inc. (VNDA): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2015-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$23.46M
Year ended 2015-12-31
n/m
3-year compound annual growth
+52.0%
5-year compound annual growth
2009-12-31: $1.92M2010-12-31: $2.89M2012-12-31: $129.0K2014-12-31: $1.58M2015-12-31: $23.46M$23.46M
2009-12-31 Cost of Revenue (USD) 2015-12-31
Period endedCost of RevenueChange YoYSource filing
2015-12-31$23.46Mn/m2016-02-12, From 2015-01-01
2014-12-31$1.58Mn/a2016-02-12, From 2014-01-01
No annual figure between 2012-12-31 and 2014-12-31.
2012-12-31$129.0Kn/a2015-03-13, From 2012-01-01
No annual figure between 2010-12-31 and 2012-12-31.
2010-12-31$2.89M+51.0%2013-02-26, From 2010-01-01
2009-12-31$1.92Mn/a2012-03-09, From 2009-01-01